Price $2.27 |
Market Cap
43M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.22
|
P/S
1.58
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-11.2K
|
FCF
-0.4
|
|
Op. Margin
-50.30%
|
Net Margin
-50.30%
|
ROE
-34.80%
|
ROI
-23.90%
|
|
ROA
-25.10%
|
EPS Growth
-64.00%
|
Current Ratio
3.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $2.96 | - | - | 106.2M | Strong Buy |
| Avalo Therapeutics Inc (AVTX) | $4.00 | - | - | 47.6M | Strong Buy |
| Statera Biopharma Inc (STAB) | $0.03 | - | - | 4.9M | Strong Buy |
| Precision Optics Corporation I (POCI) | $6.12 | - | - | 31.4M | Strong Buy |
| Clover Health Investments Corp (CLOV) | $1.25 | - | - | 443.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
